The US Food and Drug Administration should do more to ensure that advisory committee consumer representatives actually represent consumer interests, stakeholders said.
Key Takeaways
-
Public interest groups say the FDA is not doing enough to ensure that consumer representatives actually represent consumer interests on advisory committees.
-
Consumer reps often have ties to academia, industry or nonprofit groups that receive industry funding, speakers said
Many consumer representative positions on advisory committees either are vacant or filled by individuals with ties to academia, industry or patient groups, rather than true consumer or public interest organizations, several speakers said
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?